In the News

Novozymes Food and Beverages business boosts “satisfactory 2018 performance”

Global biotechnology company Novozymes has announced “a satisfactory 2018 performance,” which was in line with its initial outlook. The Danish firm has pegged its 2019 guidance of 3-6 percent organic sales growth and 28-29 percent EBIT margin. The company also highlighted organic sales growth of +4 percent (Q4: +2 percent) in 2018 and -1 percent in DKK (Q4: +1 percent). The company also reports that is was a “solid year” for its food and beverage categories with full-year sales growing by 5 percent.

Read More